Regulation of Claudins by Posttranslational Modifications and Cell-Signaling Cascades

Current Topics in Membranes

Volumn 65, Issue C, 2010, Pages 113-150

  González Mariscal, Lorenza ^a   Garay, Erika ^a   Quirós, Miguel ^a  

^a DEPARTAMENTO DE FÍSICA   (Mexico)

Author keywords

Claudins; Cytokines; Hormones; Palmitoylation; Phosphorylation; Prostaglandins

Indexed keywords

EID: 77954644289     PISSN: 10635823     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1063-5823(10)65006-5     Document Type: Book

References (112)

1. Abe T., Sugano E., Saigo Y., Tamai M. Interleukin-1beta and barrier function of retinal pigment epithelial cells (ARPE-19): Aberrant expression of junctional complex molecules. Investigative Ophthalmology and Visual Science 2003, 44:4097-4104.
2. Adamson R.H., Liu B., Fry G.N., Rubin L.L., Curry F.E. Microvascular permeability and number of tight junctions are modulated by cAMP. American Journal of Physiology 1998, 274:H1885-H1894.
3. + absorption defends from paracellular back-leakage by claudin-8 upregulation. Biochemical and Biophysical Research Communications 2009, 378:45-50.
4. Aono S., Hirai Y. Phosphorylation of claudin-4 is required for tight junction formation in a human keratinocyte cell line. Experimental Cell Research 2008, 314:3326-3339.
5. Armaly M.F. Effect of corticosteroids on intraocular pressure and fluid dynamics. II. The effect of dexamethasone in the glaucomatous eye. Archives of Ophthalmology 1963, 70:492-499.
6. Asadullah K., Sterry W., Volk H.D. Interleukin-10 therapy-Review of a new approach. Pharmacological Reviews 2003, 55:241-269.
7. Bach E.A., Aguet M., Schreiber R.D. The IFN gamma receptor: A paradigm for cytokine receptor signaling. Annual Review of Immunology 1997, 15:563-591.
8. Bai L., Zhang Z., Zhang H., Li X., Yu Q., Lin H., et al. HIV-1 Tat protein alter the tight junction integrity and function of retinal pigment epithelium: An in vitro study. BMC Infectious Diseases 2008, 8:77.
9. Baker O.J., Camden J.M., Redman R.S., Jones J.E., Seye C.I., Erb L., et al. Proinflammatory cytokines tumor necrosis factor-alpha and interferon-gamma alter tight junction structure and function in the rat parotid gland Par-C10 cell line. American Journal of Physiology. Cell Physiology 2008, 295:C1191-C1201.
10. Banan A., Zhang L.J., Shaikh M., Fields J.Z., Choudhary S., Forsyth C.B., et al. theta Isoform of protein kinase C alters barrier function in intestinal epithelium through modulation of distinct claudin isotypes: A novel mechanism for regulation of permeability. Journal of Pharmacology and Experimental Therapeutics 2005, 313:962-982.
11. Bouma G., Strober W. The immunological and genetic basis of inflammatory bowel disease. Nature Reviews. Immunology 2003, 3:521-533.
12. Boumba D., Skopouli F.N., Moutsopoulos H.M. Cytokine mRNA expression in the labial salivary gland tissues from patients with primary Sjogren's syndrome. British Journal of Rheumatology 1995, 34:326-333.
13. Bruewer M., Hopkins A.M., Hobert M.E., Nusrat A., Madara J.L. RhoA, Rac1, and Cdc42 exert distinct effects on epithelial barrier via selective structural and biochemical modulation of junctional proteins and F-actin. American Journal of Physiology. Cell Physiology 2004, 287:C327-C335.
14. Bruewer M., Luegering A., Kucharzik T., Parkos C.A., Madara J.L., Hopkins A.M., et al. Proinflammatory cytokines disrupt epithelial barrier function by apoptosis-independent mechanisms. Journal of Immunology 2003, 171:6164-6172.
15. Chen S.P., Zhou B., Willis B.C., Sandoval A.J., Liebler J.M., Kim K.J., et al. Effects of transdifferentiation and EGF on claudin isoform expression in alveolar epithelial cells. Journal of Applied Physiology 2005, 98:322-328.
16. Chen Y., Lu Q., Schneeberger E.E., Goodenough D.A. Restoration of tight junction structure and barrier function by down-regulation of the mitogen-activated protein kinase pathway in ras-transformed Madin-Darby canine kidney cells. Molecular Biology of the Cell 2000, 11:849-862.
17. Chomarat P., Banchereau J. An update on interleukin-4 and its receptor. European Cytokine Network 1997, 8:333-344.
18. Dai J., Jin W.H., Sheng Q.H., Shieh C.H., Wu J.R., Zeng R. Protein phosphorylation and expression profiling by Yin-yang multidimentional liquid chromatography (Yin-Yang MDLC) mass spectrometry. Journal of Proteome Research 2007, 6:250-262.
19. Dinarello C.A. Biologic basis for interleukin-1 in disease. Blood 1996, 87:2095-2147.
20. D'Souza T., Agarwal R., Morin P.J. Phosphorylation of claudin-3 at threonine 192 by cAMP-dependent protein kinase regulates tight junction barrier function in ovarian cancer cells. Journal of Biological Chemistry 2005, 280:26233-26240.
21. D'Souza T., Indig F.E., Morin P.J. Phosphorylation of claudin-4 by PKCepsilon regulates tight junction barrier function in ovarian cancer cells. Experimental Cell Research 2007, 313:3364-3375.
22. Duffy H.S., John G.R., Lee S.C., Brosnan C.F., Spray D.C. Reciprocal regulation of the junctional proteins claudin-1 and connexin43 by interleukin-1beta in primary human fetal astrocytes. Journal of Neuroscience 2000, 20:RC114.
23. Farquhar M.J., Harris H.J., Diskar M., Jones S., Mee C.J., Nielsen S.U., et al. Protein kinase A-dependent step(s) in hepatitis C virus entry and infectivity. Journal of Virology 2008, 82:8797-8811.
24. Felinski E.A., Cox A.E., Phillips B.E., Antonetti D.A. Glucocorticoids induce transactivation of tight junction genes occludin and claudin-5 in retinal endothelial cells via a novel cis-element. Experimental Eye Research 2008, 86:867-878.
25. Flores-Benitez D., Rincon-Heredia R., Razgado L.F., Larre I., Cereijido M., Contreras R.G. Control of tight junctions sealing: Roles of epidermal growth factor and prostaglandin E2. American Journal of Physiology. Cell Physiology 2009, 297:C611-C620.
26. Flores-Benitez D., Ruiz-Cabrera A., Flores-Maldonado C., Shoshani L., Cereijido M., Contreras R.G. Control of tight junctional sealing: Role of epidermal growth factor. American Journal of Physiology. Renal Physiology 2007, 292:F828-F836.
27. Florin A., Maire M., Bozec A., Hellani A., Chater S., Bars R., et al. Androgens and postmeiotic germ cells regulate claudin-11 expression in rat Sertoli cells. Endocrinology 2005, 146:1532-1540.
28. Flynn A.N., Buret A.G. Tight junctional disruption and apoptosis in an in vitro model of Citrobacter rodentium infection. Microbial Pathogenesis 2008, 45:98-104.
29. Forster C., Burek M., Romero I.A., Weksler B., Couraud P.O., Drenckhahn D. Differential effects of hydrocortisone and TNFalpha on tight junction proteins in an in vitro model of the human blood-brain barrier. Journal of Physiology 2008, 586:1937-1949.
30. Fox R.I., Kang H.I., Ando D., Abrams J., Pisa E. Cytokine mRNA expression in salivary gland biopsies of Sjogren's syndrome. Journal of Immunology 1994, 152:5532-5539.
31. French A.D., Fiori J.L., Camilli T.C., Leotlela P.D., O'Connell M.P., Frank B.P., et al. PKC and PKA phosphorylation affect the subcellular localization of claudin-1 in melanoma cells. International Journal of Medical Sciences 2009, 6:93-101.
32. Fries W., Muja C., Crisafulli C., Cuzzocrea S., Mazzon E. Dynamics of enterocyte tight junctions: Effect of experimental colitis and two different anti-TNF strategies. American Journal of Physiology. Gastrointestinal and Liver Physiology 2008, 294:G938-G947.
33. Fujibe M., Chiba H., Kojima T., Soma T., Wada T., Yamashita T., et al. Thr203 of claudin-1, a putative phosphorylation site for MAP kinase, is required to promote the barrier function of tight junctions. Experimental Cell Research 2004, 295:36-47.
34. Furuse M., Fujita K., Hiiragi T., Fujimoto K., Tsukita S. Claudin-1 and -2: Novel integral membrane proteins localizing at tight junctions with no sequence similarity to occludin. Journal of Cell Biology 1998, 141:1539-1550.
35. Gonzalez-Mariscal L., Lechuga S., Garay E. Role of tight junctions in cell proliferation and cancer. Progress in Histochemistry and Cytochemistry 2007, 42:1-57.
36. Gye M.C. Changes in the expression of claudins and transepithelial electrical resistance of mouse Sertoli cells by Leydig cell coculture. International Journal of Andrology 2003, 26:271-278.
37. Halse A., Tengner P., Wahren-Herlenius M., Haga H., Jonsson R. Increased frequency of cells secreting interleukin-6 and interleukin-10 in peripheral blood of patients with primary Sjogren's syndrome. Scandinavian Journal of Immunology 1999, 49:533-538.
38. Haorah J., Heilman D., Knipe B., Chrastil J., Leibhart J., Ghorpade A., et al. Ethanol-induced activation of myosin light chain kinase leads to dysfunction of tight junctions and blood-brain barrier compromise. Alcoholism, Clinical and Experimental Research 2005, 29:999-1009.
39. Haorah J., Knipe B., Gorantla S., Zheng J., Persidsky Y. Alcohol-induced blood-brain barrier dysfunction is mediated via inositol 1, 4, 5-triphosphate receptor (IP3R)-gated intracellular calcium release. Journal of Neurochemistry 2007, 100:324-336.
40. Hata A.N., Breyer R.M. Pharmacology and signaling of prostaglandin receptors: Multiple roles in inflammation and immune modulation. Pharmacology and Therapeutics 2004, 103:147-166.
41. Hellani A., Ji J., Mauduit C., Deschildre C., Tabone E., Benahmed M. Developmental and hormonal regulation of the expression of oligodendrocyte-specific protein/claudin 11 in mouse testis. Endocrinology 2000, 141:3012-3019.
42. Hershey G.K. IL-13 receptors and signaling pathways: An evolving web. Journal of Allergy and Clinical Immunology 2003, 111:677-690.
43. Heuer M., Aust G., Ode-Hakim S., Scherbaum W.A. Different cytokine mRNA profiles in Graves' disease, Hashimoto's thyroiditis, and nonautoimmune thyroid disorders determined by quantitative reverse transcriptase polymerase chain reaction (RT-PCR). Thyroid 1996, 6:97-106.
44. Honda H., Pazin M.J., Ji H., Wernyj R.P., Morin P.J. Crucial roles of Sp1 and epigenetic modifications in the regulation of the CLDN4 promoter in ovarian cancer cells. Journal of Biological Chemistry 2006, 281:21433-21444.
45. Ikari A., Atomi K., Takiguchi A., Yamazaki Y., Miwa M., Sugatani J. Epidermal growth factor increases claudin-4 expression mediated by Sp1 elevation in MDCK cells. Biochemical and Biophysical Research Communications 2009, 384:306-310.
46. Ikari A., Ito M., Okude C., Sawada H., Harada H., Degawa M., et al. Claudin-16 is directly phosphorylated by protein kinase A independently of a vasodilator-stimulated phosphoprotein-mediated pathway. Journal of Cellular Physiology 2008, 214:221-229.
47. Ikari A., Matsumoto S., Harada H., Takagi K., Degawa M., Takahashi T., et al. Dysfunction of paracellin-1 by dephosphorylation in Dahl salt-sensitive hypertensive rats. Journal of Physiological Sciences 2006, 56:379-383.
48. Ikari A., Matsumoto S., Harada H., Takagi K., Hayashi H., Suzuki Y., et al. Phosphorylation of paracellin-1 at Ser217 by protein kinase A is essential for localization in tight junctions. Journal of Cell Science 2006, 119:1781-1789.
49. Imamura M., Kojima T., Lan M., Son S., Murata M., Osanai M., et al. Oncostatin M induces upregulation of claudin-2 in rodent hepatocytes coinciding with changes in morphology and function of tight junctions. Experimental Cell Research 2007, 313:1951-1962.
50. Ishizaki T., Chiba H., Kojima T., Fujibe M., Soma T., Miyajima H., et al. Cyclic AMP induces phosphorylation of claudin-5 immunoprecipitates and expression of claudin-5 gene in blood-brain-barrier endothelial cells via protein kinase A-dependent and -independent pathways. Experimental Cell Research 2003, 290:275-288.
51. Kaal E.C., Vecht C.J. The management of brain edema in brain tumors. Current Opinion in Oncology 2004, 16:593-600.
52. Kaitu'u-Lino T.J., Sluka P., Foo C.F., Stanton P.G. Claudin-11 expression and localisation is regulated by androgens in rat Sertoli cells in vitro. Reproduction 2007, 133:1169-1179.
53. Kojima T., Takano K., Yamamoto T., Murata M., Son S., Imamura M., et al. Transforming growth factor-beta induces epithelial to mesenchymal transition by down-regulation of claudin-1 expression and the fence function in adult rat hepatocytes. Liver International 2008, 28:534-545.
54. Krause G., Winkler L., Mueller S.L., Haseloff R.F., Piontek J., Blasig I.E. Structure and function of claudins. Biochimica et Biophysica Acta 2008, 1778:631-645.
55. Lan M., Kojima T., Osanai M., Chiba H., Sawada N. Oncogenic Raf-1 regulates epithelial to mesenchymal transition via distinct signal transduction pathways in an immortalized mouse hepatic cell line. Carcinogenesis 2004, 25:2385-2395.
56. Le Moellic C., Boulkroun S., Gonzalez-Nunez D., Dublineau I., Cluzeaud F., Fay M., et al. Aldosterone and tight junctions: Modulation of claudin-4 phosphorylation in renal collecting duct cells. American Journal of Physiology. Cell Physiology 2005, 289:C1513-C1521.
57. Leotlela P.D., Wade M.S., Duray P.H., Rhode M.J., Brown H.F., Rosenthal D.T., et al. Claudin-1 overexpression in melanoma is regulated by PKC and contributes to melanoma cell motility. Oncogene 2007, 26:3846-3856.
58. Letterio J.J., Roberts A.B. Regulation of immune responses by TGF-beta. Annual Review of Immunology 1998, 16:137-161.
59. Lipschutz J.H., Li S., Arisco A., Balkovetz D.F. Extracellular signal-regulated kinases 1/2 control claudin-2 expression in Madin-Darby canine kidney strain I and II cells. Journal of Biological Chemistry 2005, 280:3780-3788.
60. Lui W.Y., Lee W.M., Cheng C.Y. Transforming growth factor-beta3 perturbs the inter-Sertoli tight junction permeability barrier in vitro possibly mediated via its effects on occludin, zonula occludens-1, and claudin-11. Endocrinology 2001, 142:1865-1877.
61. Mayan H., Vered I., Mouallem M., Tzadok-Witkon M., Pauzner R., Farfel Z. Pseudohypoaldosteronism type II: Marked sensitivity to thiazides, hypercalciuria, normomagnesemia, and low bone mineral density. Journal of Clinical Endocrinology and Metabolism 2002, 87:3248-3254.
62. Mazzon E., Cuzzocrea S. Role of TNF-alpha in lung tight junction alteration in mouse model of acute lung inflammation. Respiratory Research 2007, 8:75.
63. Mazzon E., Puzzolo D., Caputi A.P., Cuzzocrea S. Role of IL-10 in hepatocyte tight junction alteration in mouse model of experimental colitis. Molecular Medicine 2002, 8:353-366.
64. Medici D., Hay E.D., Goodenough D.A. Cooperation between snail and LEF-1 transcription factors is essential for TGF-{beta}1-induced epithelial-mesenchymal transition. Molecular Biology of the Cell 2006, 17:1871-1879.
65. Mendoza-Rodriguez C.A., Gonzalez-Mariscal L., Cerbon M. Changes in the distribution of ZO-1, occludin, and claudins in the rat uterine epithelium during the estrous cycle. Cell and Tissue Research 2005, 319:315-330.
66. Meng J., Holdcraft R.W., Shima J.E., Griswold M.D., Braun R.E. Androgens regulate the permeability of the blood-testis barrier. Proceedings of the National Academy of Sciences of the United States of America 2005, 102:16696-16700.
67. Mullin J.M., Leatherman J.M., Valenzano M.C., Huerta E.R., Verrechio J., Smith D.M., et al. Ras mutation impairs epithelial barrier function to a wide range of nonelectrolytes. Molecular Biology of the Cell 2005, 16:5538-5550.
68. Munton R.P., Tweedie-Cullen R., Livingstone-Zatchej M., Weinandy F., Waidelich M., Longo D., et al. Qualitative and quantitative analysis of protein phosphorylation in naive and stimulated mouse synaptosomal preparations. Molecular and Cellular Proteomics 2007, 6:283-293.
69. Nadolski M.J., Linder M.E. Protein lipidation. FEBS Journal 2007, 274:5202-5210.
70. Nicholls P.K., Harrison C.A., Gilchrist R.B., Farnworth P.G., Stanton P.G. Growth differentiation factor 9 is a germ cell regulator of Sertoli cell function. Endocrinology 2009, 150:2481-2490.
71. Nunbhakdi-Craig V., Machleidt T., Ogris E., Bellotto D., White C.L., Sontag E. Protein phosphatase 2A associates with and regulates atypical PKC and the epithelial tight junction complex. Journal of Cell Biology 2002, 158:967-978.
72. Ohta A., Yang S.S., Rai T., Chiga M., Sasaki S., Uchida S. Overexpression of human WNK1 increases paracellular chloride permeability and phosphorylation of claudin-4 in MDCKII cells. Biochemical and Biophysical Research Communications 2006, 349:804-808.
73. Ohyama Y., Nakamura S., Matsuzaki G., Shinohara M., Hiroki A., Fujimura T., et al. Cytokine messenger RNA expression in the labial salivary glands of patients with Sjogren's syndrome. Arthritis and Rheumatism 1996, 39:1376-1384.
74. Oshima T., Miwa H., Joh T. Aspirin induces gastric epithelial barrier dysfunction by activating p38 MAPK via claudin-7. American Journal of Physiology. Cell Physiology 2008, 295:C800-C806.
75. Oshima T., Miwa H., Joh T. Changes in the expression of claudins in active ulcerative colitis. Journal of Gastroenterology and Hepatology 2008, 23(Suppl. 2):S146-S150.
76. Oxholm P., Daniels T.E., Bendtzen K. Cytokine expression in labial salivary glands from patients with primary Sjogren's syndrome. Autoimmunity 1992, 12:185-191.
77. Pelletier R.M. The tight junctions in the testis, epididymis and vas deferens. Tight junctions 2001, 599-628. CRC Press, Boca Raton, FL. 2nd ed. M. Cereijido, J.D. Anderson (Eds.).
78. Prasad S., Mingrino R., Kaukinen K., Hayes K.L., Powell R.M., MacDonald T.T., et al. Inflammatory processes have differential effects on claudins 2, 3 and 4 in colonic epithelial cells. Laboratory Investigation 2005, 85:1139-1162.
79. Quamme G.A., de Rouffignac C. Epithelial magnesium transport and regulation by the kidney. Frontiers in Bioscience 2000, 5:D694-D711.
80. Samuel C.E. Antiviral actions of interferons. Clinical Microbiology Reviews 2001, 14:778-809.
81. Satterfield M.C., Dunlap K.A., Hayashi K., Burghardt R.C., Spencer T.E., Bazer F.W. Tight and adherens junctions in the ovine uterus: Differential regulation by pregnancy and progesterone. Endocrinology 2007, 148:3922-3931.
82. Schambelan M., Sebastian A., Rector F.C. Mineralocorticoid-resistant renal hyperkalemia without salt wasting (type II pseudohypoaldosteronism): Role of increased renal chloride reabsorption. Kidney International 1981, 19:716-727.
83. Schwarz B.T., Wang F., Shen L., Clayburgh D.R., Su L., Wang Y., et al. LIGHT signals directly to intestinal epithelia to cause barrier dysfunction via cytoskeletal and endocytic mechanisms. Gastroenterology 2007, 132:2383-2394.
84. Sethi G., Sung B., Aggarwal B.B. TNF: A master switch for inflammation to cancer. Frontiers in Bioscience 2008, 13:5094-5107.
85. Shen H.M., Pervaiz S. TNF receptor superfamily-induced cell death: Redox-dependent execution. FASEB Journal 2006, 20:1589-1598.
86. Simard A., Di Pietro E., Young C.R., Plaza S., Ryan A.K. Alterations in heart looping induced by overexpression of the tight junction protein claudin-1 are dependent on its C-terminal cytoplasmic tail. Mechanisms of Development 2006, 123:210-227.
87. Singh A.B., Sugimoto K., Dhawan P., Harris R.C. Juxtacrine activation of EGFR regulates claudin expression and increases transepithelial resistance. American Journal of Physiology. Cell Physiology 2007, 293:C1660-C1668.
88. Soma T., Chiba H., Kato-Mori Y., Wada T., Yamashita T., Kojima T., et al. Thr(207) of claudin-5 is involved in size-selective loosening of the endothelial barrier by cyclic AMP. Experimental Cell Research 2004, 300:202-212.
89. Take C., Ikeda K., Kurasawa T., Kurokawa K. Increased chloride reabsorption as an inherited renal tubular defect in familial type II pseudohypoaldosteronism. New England Journal of Medicine 1991, 324:472-476.
90. Tan K.A., De Gendt K., Atanassova N., Walker M., Sharpe R.M., Saunders P.T., et al. The role of androgens in Sertoli cell proliferation and functional maturation: Studies in mice with total or Sertoli cell-selective ablation of the androgen receptor. Endocrinology 2005, 146:2674-2683.
91. Tanaka M.N., Diaz B.L., De Souza W., Morgado-Diaz J.A. Prostaglandin E2-EP1 and EP2 receptor signaling promotes apical junctional complex disassembly of Caco-2 human colorectal cancer cells. BMC Cell Biology 2008, 9:63.
92. Tanaka M., Kamata R., Sakai R. EphA2 phosphorylates the cytoplasmic tail of claudin-4 and mediates paracellular permeability. Journal of Biological Chemistry 2005, 280:42375-42382.
93. Tanaka M., Miyajima A. Oncostatin M, a multifunctional cytokine. Reviews of Physiology Biochemistry and Pharmacology 2003, 149:39-52.
94. Tarulli G.A., Meachem S.J., Schlatt S., Stanton P.G. Regulation of testicular tight junctions by gonadotrophins in the adult Djungarian hamster in vivo. Reproduction 2008, 135:867-877.
95. Tatum R., Zhang Y., Lu Q., Kim K., Jeansonne B.G., Chen Y.H. WNK4 phosphorylates ser(206) of claudin-7 and promotes paracellular Cl(-) permeability. FEBS Letters 2007, 581:3887-3891.
96. Taya Y., O'Kane S., Ferguson M.W. Pathogenesis of cleft palate in TGF-beta3 knockout mice. Development 1999, 126:3869-3879.
97. Tedelind S., Ericson L.E., Karlsson J.O., Nilsson M. Interferon-gamma down-regulates claudin-1 and impairs the epithelial barrier function in primary cultured human thyrocytes. European Journal of Endocrinology 2003, 149:215-221.
98. Van Itallie C.M., Gambling T.M., Carson J.L., Anderson J.M. Palmitoylation of claudins is required for efficient tight-junction localization. Journal of Cell Science 2005, 118:1427-1436.
99. Villén J., Beausoleil S.A., Gerber S.A., Gygi S.P. Large-scale phosphorylation analyses of mouse liver. Proceedings of the National Academy of Sciences 2007, 104:1488-1493.
100. Wang J., Anders R.A., Wang Y., Turner J.R., Abraham C., Pfeffer K., et al. The critical role of LIGHT in promoting intestinal inflammation and Crohn's disease. Journal of Immunology 2005, 174:8173-8182.
101. Warren J.S., Ward P.A., Johnson K.J. Tumor necrosis factor: A plurifunctional mediator of acute inflammation. Modern Pathology 1988, 1:242-247.
102. Willemsen L.E., Hoetjes J.P., van Deventer S.J., van Tol E.A. Abrogation of IFN-gamma mediated epithelial barrier disruption by serine protease inhibition. Clinical and Experimental Immunology 2005, 142:275-284.
103. Wilson F.H., Disse-Nicodeme S., Choate K.A., Ishikawa K., Nelson-Williams C., Desitter I., et al. Human hypertension caused by mutations in WNK kinases. Science 2001, 293:1107-1112.
104. Wisner D.M., Harris L.R., Green C.L., Poritz L.S. Opposing regulation of the tight junction protein claudin-2 by interferon-gamma and interleukin-4. Journal of Surgical Research 2008, 144:1-7.
105. Wolburg H., Neuhaus J., Kniesel U., Krauss B., Schmid E.M., Ocalan M., et al. Modulation of tight junction structure in blood-brain barrier endothelial cells. Effects of tissue culture, second messengers and cocultured astrocytes. Journal of Cell Science 1994, 107(Pt 5):1347-1357.
106. Xu H., Gonzalez J.M., Ofori E., Elovitz M.A. Preventing cervical ripening: The primary mechanism by which progestational agents prevent preterm birth?. American Journal of Obstetrics and Gynecology 2008, 198:314-318.
107. Yamamoto M., Ramirez S.H., Sato S., Kiyota T., Cerny R.L., Kaibuchi K., et al. Phosphorylation of claudin-5 and occludin by rho kinase in brain endothelial cells. American Journal of Pathology 2008, 172:521-533.
108. Yamamoto T., Kojima T., Murata M., Takano K., Go M., Chiba H., et al. IL-1beta regulates expression of Cx32, occludin, and claudin-2 of rat hepatocytes via distinct signal transduction pathways. Experimental Cell Research 2004, 299:427-441.
109. Yamauchi K., Rai T., Kobayashi K., Sohara E., Suzuki T., Itoh T., et al. Disease-causing mutant WNK4 increases paracellular chloride permeability and phosphorylates claudins. Proceedings of the National Academy of Sciences of the United States of America 2004, 101:4690-4694.
110. Yoo J., Nichols A., Mammen J., Calvo I., Song J.C., Worrell R.T., et al. Bryostatin-1 enhances barrier function in T84 epithelia through PKC-dependent regulation of tight junction proteins. American Journal of Physiology. Cell Physiology 2003, 285:C300-C309.
111. Zeissig S., Burgel N., Gunzel D., Richter J., Mankertz J., Wahnschaffe U., et al. Changes in expression and distribution of claudin 2, 5 and 8 lead to discontinuous tight junctions and barrier dysfunction in active Crohn's disease. Gut 2007, 56:61-72.
112. Zwiers A., Fuss I.J., Leijen S., Mulder C.J., Kraal G., Bouma G. Increased expression of the tight junction molecule claudin-18 A1 in both experimental colitis and ulcerative colitis. Inflammatory Bowel Diseases 2008, 14:1652-1659.